The Claim
BPC 157 reduces portal hypertension and restores vascular function in animal models of liver cirrhosis and vascular occlusion without altering coagulation parameters.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
BPC 157 lowers elevated blood pressure in the liver's blood vessels and repairs damaged blood vessel function in animals with liver scarring or blocked blood vessels, without affecting blood clotting.
See the scientific wording
BPC 157 attenuates portal hypertension and reverses vascular failure in models of liver cirrhosis and vascular occlusion, suggesting a unique ability to restore blood flow and vascular function without disrupting coagulation.
BPC 157 fixes broken blood vessels by balancing nitric oxide levels and changing the physical structure of vessel walls within minutes, which opens new pathways for blood to flow around blockages and lowers pressure in the liver's main blood vessels without affecting blood clotting.
What the research says
1 studyIn animals with severe liver damage or blocked blood vessels, BPC 157 helped fix the damaged blood vessels and improved blood flow without causing dangerous clots.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.